NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT01419795 2017-07-27Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Terminated3 enrolled 10 charts
NCT01274533 2016-05-23Lenalidomide in HTLV-1 Adult T-Cell LeukemiaColumbia UniversityPhase 2 Completed4 enrolled 2 charts
NCT01116154 2010-12-09Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Terminated30 enrolled